Stay updated with breaking news from Aezs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock analysts at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research note issued on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “buy” rating and set a $28.00 price target on shares of Aeterna Zentaris in a […]
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report released on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $28.00 price target on shares of Aeterna Zentaris in a report on Thursday, August 10th. […]
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $28.00 target price on shares of Aeterna Zentaris in a research note on […]
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 price objective on shares of Aeterna Zentaris in a report on Thursday, August 10th. […]
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and issued a $28.00 price target on shares of Aeterna Zentaris in a research note on Thursday, […]